Complete financial analysis of McKesson Corporation (MCK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of McKesson Corporation, a leading company in the Medical – Distribution industry within the Healthcare sector.
You may be interested
- Tokyo Plast International Limited (TOKYOPLAST.BO) Income Statement Analysis – Financial Results
- The Lead Co., Inc. (6982.T) Income Statement Analysis – Financial Results
- Alliance Entertainment Holding Corporation (AENT) Income Statement Analysis – Financial Results
- Bright Horizons Family Solutions Inc. (BFAM) Income Statement Analysis – Financial Results
- Cascade Acquisition Corp. (CAS) Income Statement Analysis – Financial Results
McKesson Corporation (MCK)
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 308.95B | 276.71B | 263.97B | 238.23B | 231.05B | 214.32B | 208.36B | 198.53B | 190.88B | 179.05B | 137.61B | 122.46B | 122.73B | 112.08B | 108.70B | 106.63B | 101.70B | 92.98B | 88.05B | 80.51B | 69.51B | 57.12B | 50.01B | 42.01B | 36.73B | 30.38B | 20.86B | 12.89B | 13.72B | 13.19B |
| Cost of Revenue | 296.37B | 264.35B | 250.84B | 226.08B | 219.03B | 202.57B | 197.17B | 187.26B | 179.47B | 167.63B | 129.30B | 115.47B | 116.17B | 106.11B | 103.03B | 101.25B | 96.69B | 88.65B | 84.19B | 77.05B | 66.26B | 54.02B | 47.21B | 39.58B | 34.21B | 27.52B | 19.25B | 11.78B | 12.50B | 12.03B |
| Gross Profit | 12.58B | 12.36B | 13.13B | 12.15B | 12.02B | 11.75B | 11.18B | 11.27B | 11.42B | 11.41B | 8.31B | 6.98B | 6.57B | 5.97B | 5.68B | 5.38B | 5.01B | 4.33B | 3.86B | 3.46B | 3.25B | 3.10B | 2.80B | 2.43B | 2.52B | 2.86B | 1.61B | 1.11B | 1.22B | 1.16B |
| Gross Profit Ratio | 4.07% | 4.47% | 4.97% | 5.10% | 5.20% | 5.48% | 5.37% | 5.68% | 5.98% | 6.37% | 6.04% | 5.70% | 5.35% | 5.33% | 5.22% | 5.04% | 4.93% | 4.66% | 4.39% | 4.30% | 4.67% | 5.43% | 5.59% | 5.79% | 6.87% | 9.43% | 7.71% | 8.61% | 8.88% | 8.82% |
| Research & Development | 179.00M | 89.00M | 70.00M | 74.00M | 96.00M | 71.00M | 125.00M | 341.00M | 392.00M | 392.00M | 456.00M | 480.00M | 440.00M | 407.00M | 376.00M | 364.00M | 347.00M | 284.00M | 223.00M | 182.00M | 172.70M | 149.40M | 135.10M | 147.50M | 112.60M | 114.70M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.91B | 15.55B | 21.07B | 17.70B | 18.34B | 8.40B | 8.14B | 7.47B | 7.28B | 7.90B | 5.42B | 2.35B | 3.07B | 2.76B | 2.57B | 3.08B | 3.19B | 2.79B | 2.48B | 2.27B | 2.09B | 2.02B | 1.95B | 2.08B | 2.05B | 2.22B | 1.16B | 944.50M | 872.90M | 1.12B |
| Selling & Marketing | 1.10B | -7.78B | -10.54B | -8.85B | -9.17B | -8.40B | -8.14B | -7.47B | -7.28B | -7.90B | -5.42B | 1.85B | 764.00M | 767.00M | 746.00M | 743.00M | 744.00M | 673.00M | 611.00M | 550.10M | 513.10M | 499.00M | 427.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.20B | 7.78B | 10.54B | 8.85B | 9.17B | 8.40B | 8.14B | 7.80B | 7.67B | 8.29B | 5.87B | 4.20B | 149.00M | 3.94B | 3.31B | 3.82B | 3.19B | 2.79B | 2.48B | 2.27B | 2.09B | 2.02B | 1.95B | 2.08B | 2.05B | 2.22B | 1.16B | 944.50M | 872.90M | 1.12B |
| Other Expenses | 298.00M | 497.00M | 259.00M | 223.00M | 12.00M | 182.00M | 130.00M | 90.00M | 58.00M | 63.00M | 32.00M | 10.00M | 3.21B | 2.98B | -20.00M | 3.08B | -5.00M | -6.00M | 45.00M | 1.20B | 0.00 | 0.00 | 22.00M | 111.60M | 201.30M | 199.30M | 87.20M | 71.80M | 71.30M | 69.80M |
| Operating Expenses | 8.68B | 7.78B | 10.54B | 8.85B | 9.26B | 8.47B | 8.26B | 7.80B | 7.67B | 8.29B | 5.87B | 4.68B | 4.42B | 3.94B | 3.67B | 4.18B | 3.53B | 3.07B | 2.75B | 3.66B | 2.26B | 2.17B | 2.10B | 2.33B | 2.37B | 2.53B | 1.25B | 1.02B | 944.20M | 1.19B |
| Cost & Expenses | 305.04B | 272.13B | 261.37B | 234.93B | 228.29B | 211.04B | 205.44B | 195.06B | 187.14B | 175.93B | 135.17B | 120.15B | 120.59B | 110.05B | 106.69B | 105.44B | 100.23B | 91.71B | 86.94B | 80.71B | 68.52B | 56.19B | 49.31B | 41.91B | 36.58B | 30.05B | 20.50B | 12.79B | 13.44B | 13.22B |
| Interest Income | 118.00M | 107.00M | 10.00M | 12.00M | 49.00M | 39.00M | 48.00M | 29.00M | 18.00M | 20.00M | 23.00M | 22.00M | 19.00M | 18.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 252.00M | 248.00M | 178.00M | 217.00M | 249.00M | 264.00M | 283.00M | 308.00M | 353.00M | 374.00M | 303.00M | 240.00M | 251.00M | 222.00M | 187.00M | 144.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 635.00M | 857.00M | 1.00B | 1.22B | 922.00M | 949.00M | 951.00M | 910.00M | 885.00M | 1.02B | 704.00M | 591.00M | 551.00M | 496.00M | 474.00M | 441.00M | 371.00M | 295.00M | 266.00M | 250.90M | 232.10M | 203.70M | 207.50M | 246.10M | 201.30M | 199.30M | 87.20M | 71.80M | 71.30M | 69.80M |
| EBITDA | 4.67B | 5.74B | 3.11B | -3.60B | 2.32B | 4.06B | 3.86B | 4.39B | 4.56B | 4.14B | 3.06B | 2.74B | 2.72B | 2.33B | 2.53B | 1.65B | 1.85B | 1.56B | 1.39B | 29.00M | 1.21B | 929.90M | 905.00M | 450.30M | 332.10M | 531.50M | 449.40M | 164.60M | 345.40M | 50.10M |
| EBITDA Ratio | 1.51% | 2.06% | 1.37% | 1.85% | 1.12% | 1.97% | 1.80% | 2.25% | 2.46% | 2.34% | 2.30% | 2.39% | 2.20% | 2.26% | 2.28% | 1.54% | 1.80% | 1.66% | 1.46% | 1.48% | 1.68% | 1.90% | 1.79% | 1.01% | 0.25% | 1.75% | 2.15% | 1.28% | 2.52% | 0.26% |
| Operating Income | 3.91B | 4.38B | 2.85B | 3.52B | 1.66B | 886.00M | 762.00M | 7.11B | 3.55B | 2.97B | 2.37B | 2.32B | 2.15B | 1.82B | 2.01B | 1.20B | 1.48B | 1.26B | 1.11B | -190.50M | 983.40M | 929.90M | 693.60M | 96.40M | 158.20M | 332.20M | 362.20M | 92.80M | 274.10M | -30.10M |
| Operating Income Ratio | 1.27% | 1.58% | 1.08% | 1.48% | 0.72% | 0.41% | 0.37% | 3.58% | 1.86% | 1.66% | 1.72% | 1.89% | 1.75% | 1.62% | 1.85% | 1.12% | 1.45% | 1.36% | 1.27% | -0.24% | 1.41% | 1.63% | 1.39% | 0.23% | 0.43% | 1.09% | 1.74% | 0.72% | 2.00% | -0.23% |
| Total Other Income/Expenses | -120.00M | 249.00M | -110.00M | 6.00M | -1.35B | -276.00M | -523.00M | -231.00M | -295.00M | -311.00M | -343.00M | -396.00M | -230.00M | -186.00M | -144.00M | -132.00M | -21.00M | 33.00M | 44.00M | -54.50M | -72.00M | -74.50M | -87.50M | -196.30M | 148.70M | -130.20M | -109.40M | -61.70M | -44.40M | -23.40M |
| Income Before Tax | 3.79B | 4.63B | 1.93B | -5.03B | 1.14B | 610.00M | 239.00M | 6.89B | 3.25B | 2.66B | 2.10B | 1.92B | 1.92B | 1.64B | 1.86B | 1.06B | 1.46B | 1.30B | 1.16B | -239.80M | 911.40M | 855.40M | 601.20M | 9.60M | 306.90M | 202.00M | 253.50M | 36.40M | 224.10M | -81.70M |
| Income Before Tax Ratio | 1.23% | 1.67% | 0.73% | -2.11% | 0.50% | 0.28% | 0.11% | 3.47% | 1.70% | 1.48% | 1.52% | 1.57% | 1.56% | 1.46% | 1.71% | 1.00% | 1.43% | 1.39% | 1.32% | -0.30% | 1.31% | 1.50% | 1.20% | 0.02% | 0.84% | 0.66% | 1.22% | 0.28% | 1.63% | -0.62% |
| Income Tax Expense | 629.00M | 905.00M | 636.00M | -695.00M | 18.00M | 356.00M | -53.00M | 1.61B | 908.00M | 815.00M | 742.00M | 581.00M | 516.00M | 505.00M | 601.00M | 241.00M | 468.00M | 329.00M | 421.00M | -83.10M | 264.90M | 293.30M | 182.60M | 52.30M | 122.30M | 117.10M | 98.60M | 31.30M | 88.70M | 111.50M |
| Net Income | 3.00B | 3.56B | 1.11B | -4.34B | 900.00M | 34.00M | 67.00M | 5.07B | 2.26B | 1.48B | 1.26B | 1.34B | 1.40B | 1.20B | 1.26B | 823.00M | 990.00M | 913.00M | 751.00M | -156.70M | 646.50M | 555.40M | 418.60M | -48.30M | 723.70M | 84.90M | 154.90M | 133.90M | 135.40M | 404.50M |
| Net Income Ratio | 0.97% | 1.29% | 0.42% | -1.82% | 0.39% | 0.02% | 0.03% | 2.55% | 1.18% | 0.82% | 0.92% | 1.09% | 1.14% | 1.07% | 1.16% | 0.77% | 0.97% | 0.98% | 0.85% | -0.19% | 0.93% | 0.97% | 0.84% | -0.11% | 1.97% | 0.28% | 0.74% | 1.04% | 0.99% | 3.07% |
| EPS | 22.54 | 25.23 | 7.31 | -27.02 | 4.97 | 0.17 | 0.32 | 22.95 | 9.82 | 6.37 | 5.51 | 5.71 | 5.70 | 4.65 | 4.70 | 2.99 | 3.40 | 3.06 | 2.46 | -0.53 | 2.23 | 1.92 | 1.47 | -0.17 | 2.57 | 0.31 | 1.14 | 0.83 | 1.53 | 4.60 |
| EPS Diluted | 22.39 | 25.04 | 7.23 | -27.02 | 4.95 | 0.17 | 0.32 | 22.73 | 9.70 | 6.27 | 5.41 | 5.59 | 5.59 | 4.57 | 4.62 | 2.95 | 3.32 | 2.99 | 2.38 | -0.53 | 2.19 | 1.88 | 1.43 | -0.17 | 2.55 | 0.31 | 1.10 | 0.80 | 1.45 | 4.43 |
| Weighted Avg Shares Out | 133.20M | 141.10M | 152.30M | 160.60M | 181.00M | 196.30M | 208.00M | 221.00M | 230.00M | 232.00M | 229.00M | 235.00M | 246.00M | 258.00M | 269.00M | 275.00M | 291.00M | 298.00M | 306.00M | 294.00M | 290.00M | 289.30M | 285.20M | 283.10M | 281.30M | 275.20M | 282.10M | 83.65M | 88.50M | 87.93M |
| Weighted Avg Shares Out (Dil) | 134.10M | 142.20M | 154.10M | 160.60M | 182.00M | 197.30M | 209.00M | 223.00M | 233.00M | 235.00M | 233.00M | 239.00M | 251.00M | 263.00M | 273.00M | 279.00M | 298.00M | 305.00M | 316.00M | 294.00M | 299.00M | 298.80M | 298.10M | 283.10M | 284.20M | 275.20M | 282.10M | 84.39M | 93.38M | 91.31M |
Jim Cramer Says 4 Large Cap Dividend Stocks Are Sizzling December Buys
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%.
McKesson Corporation (MCK) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
McKesson Corporation (NYSE:MCK ) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 8:20 AM ET Company Participants Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Elizabeth Anderson Thank you...
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
McKesson Stock Gains 34.1% YTD: What's Driving the Rally?
MCK continues to gain because of robust segmental performance and raised fiscal 2025 guidance.
MCK Stock Down Despite Latest Partnership to Boost SCD Treatment
The availability of the FDA-approved drug via McKesson's cell and gene therapies business is expected to give patients improved treatment options for SCD.
All You Need to Know About McKesson (MCK) Rating Upgrade to Buy
McKesson (MCK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Here is Why Growth Investors Should Buy McKesson (MCK) Now
McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
Source: https://incomestatements.info
Category: Stock Reports